Adaptive Biotechnologies Corporation (NAS: ADPT) Stock Analysis & Fundamentals | ScreenerHero

Create free account

ADPTAdaptive Biotechnologies Corporation

NAS · US · Healthcare · Diagnostics & Research · adaptivebiotech.com

21.45USD+2.34%Mkt Cap: 3.43B $P/E: —1d ago

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a su…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Pricier

1M Perf

Lower

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap3.43B $

Enterprise Value3.43B $

Revenue (TTM)295.41M $

Gross Profit205.62M $

Net Income (TTM)-59.50M $

Revenue/Share1.927 USD

Last Price21.45 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees624

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS00650F1093

Valuation

P/E (Trailing)—

P/E (Forward)-84.83

PEG—

EV/EBITDA-115.18

EV/Revenue11.61

P/S11.62

P/B15.83

EPS (TTM)-0.32

EPS (Forward)-0.25

52W Range

9.95599% of range21.55

52W High21.55 USD

52W Low9.955 USD

Profitability

Gross Margin74.24%

Oper. Margin-27.10%

EBITDA Margin-10.08%

Profit Margin-21.48%

ROE-27.19%

ROA-11.60%

Growth

Revenue Growth35.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF-45.99M $

CapEx (TTM)2.96M $

FCF Margin5.45%

FCF Yield0.47%

Net Debt-10.15M $

Net Debt/EBITDA0.34

Balance Sheet

Debt/Equity0.36

Current Ratio3.35

Quick Ratio3.08

Book Value/Sh1.355 USD

Cash/Share1.364 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.5 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)20.29 USD

Upside (mean)-5.4%

Target Range18.00 USD – 22.00 USD

$18.00-5.4% to mean$22.00

# Analysts7

Ownership

Shares Out.160.04M

Float125.15M

Insiders1.84%

Institutions96.34%

Short Interest

Short Ratio3.5d

Short % Float6.03%

Short % Out.4.78%

Shares Short7.65M

Short (prev mo.)8.90M

Technical

SMA 5015.46 (+38.7%)

SMA 20015.66 (+37.0%)

Beta2.15

S&P 52W Chg20.05%

Avg Vol (30d)2.83M

Avg Vol (10d)5.11M

Technical Indicators

RSI (14)74.2

MACD1.3809

MACD Signal1.0251

MACD Hist.+0.3558

BB Upper20.98 USD

BB Middle17.51 USD

BB Lower14.05 USD

BB Width39.56%

ATR (14)1.222 USD

Vol Ratio (20d)0.97x